Results of the First U.S. Double-Blind, Placebo-Controlled, Multicenter Clinical Study in Asthma with Pranlukast, a Novel Leukotriene Receptor Antagonist

Double Blind ◽

Double Blind Placebo ◽

Leukotriene Receptor ◽

Multicenter Clinical Study

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid

Clinical & Experimental Allergy ◽

10.1046/j.1365-2222.2001.01189.x ◽

2001 ◽

Vol 31 (10) ◽

pp. 1607-1614 ◽

Cited By ~ 109

Author(s):

M. L. Pacor ◽

G. Di Lorenzo ◽

R. Corrocher

Keyword(s):

Acetylsalicylic Acid ◽

Receptor Antagonist ◽

Chronic Urticaria ◽

Food Additive ◽

Double Blind ◽

Double Blind Placebo ◽

The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial

European Journal of Pharmacology ◽

10.1016/j.ejphar.2021.174295 ◽

2021 ◽

pp. 174295

Author(s):

Mahmoud Samy Abdallah ◽

Ahmed Hossam Eldeen ◽

Sally Said Tantawy ◽

Tarek Mohamed Mostafa

Keyword(s):

Receptor Antagonist ◽

Controlled Trial ◽

Proof Of Concept ◽

Double Blind ◽

Double Blind Placebo ◽

Alcoholic Steatohepatitis ◽

A double-blind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans

Journal of Hepato-Biliary-Pancreatic Surgery ◽

10.1007/s00534-004-0890-y ◽

2004 ◽

Vol 11 (4) ◽

pp. 255-259 ◽

Cited By ~ 6

Author(s):

Mark T. Cartmell ◽

Derek A. O’Reilly ◽

Christine Porter ◽

Andrew N. Kingsnorth

Keyword(s):

Chronic Pancreatitis ◽

Receptor Antagonist ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma

Thorax ◽

10.1136/thx.52.6.523 ◽

1997 ◽

Vol 52 (6) ◽

pp. 523-527 ◽

Cited By ~ 76

Author(s):

N. C. Barnes ◽

J. C. Pujet

Keyword(s):

Clinical Study ◽

Receptor Antagonist ◽

Telmisartan combined with probucol effectively reduces urinary protein in patients with type 2 diabetes: A randomized double‐blind placebo‐controlled multicenter clinical study

Journal of Diabetes ◽

10.1111/1753-0407.12347 ◽

2015 ◽

Vol 8 (5) ◽

pp. 677-685 ◽

Cited By ~ 2

Author(s):

Hanyu Zhu ◽

Xiangmei Chen ◽

Guangyan Cai ◽

Ying Zheng ◽

Moyan Liu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Study ◽

Urinary Protein ◽

Double Blind ◽

Double Blind Placebo ◽

Multicenter Clinical Study

The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: A single-blind, placebo-controlled, crossover clinical study

Journal of Allergy and Clinical Immunology ◽

10.1067/mai.2002.126676 ◽

2002 ◽

Vol 110 (3) ◽

pp. 484-488 ◽

Cited By ~ 97

Author(s):

Zülal Erbagci

Keyword(s):

Clinical Study ◽

Receptor Antagonist ◽

Chronic Idiopathic Urticaria ◽

Leukotriene Receptor ◽

Single Blind

Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic AsthmaA Multicenter, Randomized, Double-blind Trial

Archives of Internal Medicine ◽

10.1001/archinte.158.11.1213 ◽

1998 ◽

Vol 158 (11) ◽

pp. 1213 ◽

Cited By ~ 337

Author(s):

Theodore F. Reiss

Keyword(s):

Receptor Antagonist ◽

Chronic Asthma ◽

Double Blind Trial ◽

Double Blind ◽

Once Daily ◽

Blind Trial ◽

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study

Cardiology Journal ◽

10.5603/cj.a2021.0056 ◽

2021 ◽

Author(s):

Jacek Kubica ◽

Piotr Adamski ◽

Piotr Niezgoda ◽

Aldona Kubica ◽

Przemysław Podhajski ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Clinical Study ◽

Antiplatelet Therapy ◽

Double Blind ◽

New Approach ◽

Double Blind Placebo ◽

Coronary Syndrome ◽

Multicenter Clinical Study

Efficacy of montelukast, a leukotriene receptor antagonist, for the treatment of dysmenorrhea: A prospective, double-blind, randomized, placebo-controlled study

European Journal of Obstetrics & Gynecology and Reproductive Biology ◽

10.1016/j.ejogrb.2009.10.030 ◽

2010 ◽

Vol 148 (2) ◽

pp. 195-198 ◽

Cited By ~ 6

Author(s):

Hiroyuki Fujiwara ◽

Ryo Konno ◽

Sachiho Netsu ◽

Kohei Odagiri ◽

Akiyo Taneichi ◽

...

Keyword(s):

Receptor Antagonist ◽

Controlled Study ◽

Double Blind ◽

Airway mechanics after withdrawal of a leukotriene receptor antagonist in children with mild persistent asthma: Double‐blind, randomized, cross‐over study

Pediatric Pulmonology ◽

10.1002/ppul.25085 ◽

2020 ◽

Vol 55 (12) ◽

pp. 3279-3286

Author(s):

Ju Hee Kim ◽

Shinhae Lee ◽

Youn Ho Shin ◽

Eun Kyo Ha ◽

Seung Won Lee ◽

...

Keyword(s):

Receptor Antagonist ◽

Persistent Asthma ◽

Double Blind ◽

Airway Mechanics ◽

Leukotriene Receptor ◽

Mild Persistent Asthma